About Abbott Laboratories
Abbott is a diversified healthcare company headquartered in Abbott Park, Illinois, spanning diagnostics, medical devices (including the FreeStyle Libre), nutrition and established pharmaceuticals.
Milestones
Milestones as listed on abbott.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Leadership Team
Leadership as listed on abbott.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Products & Services
Products and services as listed on abbott.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
FreeStyle Libre
Continuous glucose monitoring system for people with diabetes.
Source: abbott.comLingo
Biowearable for people looking to understand their health and wellness; received FDA clearance in 2024.
Source: abbott.comSites in Ireland
Dublin
Abbott Ireland headquarters and established pharmaceuticals operations.
Source: abbott.comGalway
Abbott Rapid Dx International site supporting rapid diagnostics.
Source: abbott.comSites as listed on abbott.com, checked 26 Sep 2026. Details can change; the linked page is the authoritative source.
Pipeline & Regulatory Record
What public registers list for Abbott Laboratories: clinical trials it sponsors, FDA device clearances, Irish licences, recent approvals and supply shortages. Rebuilt daily, last on 7 Oct 2026.
Clinical trials 76 in our ClinicalTrials.gov registers
| Study | Phase | Status |
|---|---|---|
| Comprehensive LEFt Atrial Appendage Occlusion With Rhythm Restoration NCT07523620 · site in Ireland · Atrial Fibrillation (AF), Paroxysmal AF |
Not applicable | Recruiting |
| BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF NCT07181590 · site in Ireland · Paroxysmal AF, Atrial Arrhythmia |
Not applicable | Recruiting |
| Abbott Structural Heart Device Registry NCT06590467 · site in Ireland · Heart Diseases, ASD - Atrial Septal Defect |
Observational | Recruiting |
| Early Feasibility Study (EFS) of Abbott's Balloon-expandable (BE) TAVI System for the Treatment of Severe, Symptomatic Aortic Stenosis NCT07116551 · Symptomatic Severe Aortic Stenosis |
Not applicable | Active, closed |
| Cephea South America Feasibility Study NCT07244939 · Mitral Regurgitation, Mitral Stenosis |
Not applicable | Active, closed |
| ASCEND CSP IDE Study NCT06830746 · Heart Failure, Ventricular Arrythmia |
Not applicable | Active, closed |
| TECTONIC CAD IVL IDE Study NCT06885177 · Coronary Artery Calcification, Coronary Artery Disease |
Not applicable | Active, closed |
| Abbott Medical - VERITAS Study NCT06707688 · Atrial Fibrillation (AF), Stoke |
Not applicable | Active, closed |
| Esprit BTK Post-Approval Study NCT06656364 · Chronic Limb-Threatening Ischemia |
Not applicable | Active, closed |
| Clinical Evaluation of the i-STAT ACTpro Cartridge in an Adult Population NCT07382076 · Activated Clotting Time |
Observational | Active, closed |
Showing 10 of 76, trials with Irish sites first. The full lists are on the sponsor pages below.
All trials by sponsor name 4 registry names
Drugs in these trials 1 compounds
FDA 510(k) device clearances 15 · 10 to an Irish-based entity
- Anti-HCV NextK262156 · Abbott Laboratories · 23 Sep 2026 · Class 2
- EnSite™ X EP SystemK261729 · Abbott Medical · 17 Sep 2026 · Class 2
- ID NOW Influenza A & B 2; ID NOW RSV; ID NOW Strep A 2; ID NOW COVID-19 2.0K262747 · Abbott Diagnostics Scarborough, Inc. · 31 Aug 2026 · Class 2
- Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring SystemDEN250049 · Abbott Diabetes Care · 25 Aug 2026 · Class 2
- EnSite™ X EP SystemK262006 · Abbott Medical · 15 Jul 2026 · Class 2
- Glucose2K252357 · Abbott Ireland · 24 Oct 2025 · Class 2
- Calcium2K244042 · Abbott Ireland · 10 Feb 2025 · Class 2
- Alkaline Phosphatase2K223317 · Abbott Ireland Diagnostics Division · 21 Jul 2023 · Class 2
- Total Bilirubin2K223324 · Abbott Ireland Diagnostics Division · 29 Dec 2022 · Class 2
- Cholesterol2K203597 · Abbott Ireland Diagnostics Division · 30 Jun 2022 · Class 1
Clearances in our FDA device register: every clearance to an Irish-based applicant, plus the last 90 days worldwide.
Group (Abbott Laboratories): founded 1888, headquarters North Chicago, website abbott.com. Wikidata Q306764 · Wikipedia. From Wikidata (CC0), matched by the group's SEC filer number.
How this is matched: register records are linked to this page by the organisation name they carry, here Abbott Medical Devices; Abbott Diabetes Care; Abbott Point of Care; Abbott Nutrition; Abbott Rapid Dx; Abbott Ireland and 4 more. Spot a wrong match? Tell us.
Financials & Irish Entities
From the annual reports Abbott Laboratories files with the US Securities and Exchange Commission (10-K, US GAAP), in USD as reported. Latest financial year: to Dec 2025.
| Year to | Revenue | R&D | R&D % | Net income | Filing |
|---|---|---|---|---|---|
| Dec 2025 | $44.33bn | $2.94bn | 6.6% | $6.52bn | 10-K 2026 |
| Dec 2024 | $41.95bn | $2.84bn | 6.8% | $13.40bn | 10-K 2026 |
| Dec 2023 | $40.11bn | $2.74bn | 6.8% | $5.72bn | 10-K 2026 |
| Dec 2022 | $43.65bn | $2.89bn | 6.6% | $6.93bn | 10-K 2025 |
| Dec 2021 | $43.08bn | $2.74bn | 6.4% | $7.07bn | 10-K 2024 |
R&D is shown as tagged in the filing, which for this company can exclude acquired in-process R&D. Each year is taken from the most recent annual report that includes it, so earlier years reflect any later restatement. Source: SEC EDGAR (XBRL financial data). Compare companies on the pharma company financials register.
Companies registered in Ireland 13 active in the CRO register
| Company | CRO no. | Registered | Last accounts |
|---|---|---|---|
| Abbott Laboratories, Ireland, Limited LTD - Private Company Limited by Shares · LEI 549300AFDWMWLWON8B88 | 11542 | 1946 | Dec 2024 |
| Abbott Ireland External company | 908940 | 1983 | — |
| Abbott Ireland Limited LTD - Private Company Limited by Shares | 99308 | 1984 | Dec 2024 |
| Abbott Mature Products Management Limited LTD - Private Company Limited by Shares | 438533 | 2007 | Dec 2024 |
| Abbott Nutrition Limited LTD - Private Company Limited by Shares | 438946 | 2007 | Dec 2024 |
| Abbott Rapid DX International Limited LTD - Private Company Limited by Shares · LEI 635400OV6FK9KWLBDC06 | 495964 | 2011 | Dec 2024 |
| Alere Technologies Holdings Unlimited Company ULC - Private Unlimited Company · LEI 549300IUFNZ7YSTLYB94 | 536684 | 2013 | Dec 2024 |
| Abbott Medical Ireland Limited LTD - Private Company Limited by Shares | 558406 | 2015 | Dec 2024 |
| Abbott Ireland Financing Designated Activity Company DAC - Designated Activity Company (limited by shares) · LEI 54930021QV18ZVZQDE71 | 633034 | 2018 | Dec 2024 |
| Abbott Rapid Diagnostics International Subsidiary Unlimited Company ULC - Private Unlimited Company | 643367 | 2019 | Dec 2024 |
| Abbott Rapid Diagnostics International Holdco Unlimited Company ULC - Private Unlimited Company · LEI 254900B0IM71H24LPW57 | 643943 | 2019 | Dec 2024 |
| Abbott Rapid Diagnostics International Unlimited Company ULC - Private Unlimited Company · LEI 254900VSV4IECESLXX27 | 643942 | 2019 | Dec 2024 |
| Diversified Healthcare Solutions Operations Unlimited Company ULC - Private Unlimited Company · LEI 254900ZWL7QWGYA3IA84 | 753621 | 2023 | Dec 2024 |
From the Companies Registration Office (CRO Open Data, CC BY 4.0). A company is listed when GLEIF's legal entity register links it to Abbott Laboratories as its ultimate parent, or when we checked its name and registered address by hand. Branches of foreign companies appear as "External company". Spot a missing or wrong entry? Tell us.